You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 18, November 14, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Quality of Care
 •Quality of Care, Other
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lymph Node Counts in Colon Cancer Surgery

Lessons for Users of Quality Indicators

Marko Simunovic, MD, MPH; Nancy N. Baxter, MD, PhD

JAMA. 2007;298(18):2194-2195.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

For patients undergoing curative colon cancer surgery, the presence of positive lymph nodes predicts a greater risk of disease recurrence than negative lymph nodes. Numerous studies have reported that for patients with negative nodes, survival is worse when relatively few lymph nodes are evaluated.1 Most reports suggest this is due to understaging (ie, positive lymph nodes are missed as a result of poor surgical or pathological practices) and consequently patients are falsely identified as having negative nodes. These incorrectly staged patients have a survival risk commensurate with their true node-positive status; additionally, such patients are less likely to receive (and potentially benefit from) chemotherapy. In the hope of improving patient outcomes, several stakeholder groups have identified the evaluation of 12 or more lymph nodes following colon cancer resection as an indicator of the quality of practice provided by individual surgeons or . . . [Full Text of this Article]

Author Affiliations: Department of Surgery, Hamilton Health Sciences, and Departments of Surgery, Oncology, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada (Dr Simunovic); and Department of Surgery and Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada (Dr Baxter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer
, , , , , and
JAMA. ;298():2149-2154.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Lymph Node Evaluation With Colorectal Cancer Resection: Does It Improve Detection of Stage III Disease?
Kukreja et al.
Arch Surg 2009;144:612-617.
ABSTRACT | FULL TEXT  

Lymph Node Evaluation as a Colon Cancer Quality Measure: A National Hospital Report Card
Bilimoria et al.
JNCI J Natl Cancer Inst 2008;100:1310-1317.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.